AzTrials
AzTrials

Post Traumatic Stress DisorderNCT02449421

Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD

A study testing Quality Improvement Learning Community and Fidelity-oriented Learning Community in people with Post Traumatic Stress Disorder, run by Toronto Metropolitan University at 3 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of the study is to compare the impact of two strategies to sustain and improve the delivery of an evidence-based psychotherapy for PTSD, Cognitive Processing Therapy (CPT) in three different mental health systems. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Post Traumatic Stress Disorder
What is being tested?
Quality Improvement Learning Community and Fidelity-oriented Learning Community
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
3 sitesin 2 countries
Study dates
6 May 2015to Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All clinicians that provide psychotherapy to patients with PTSD
  • Agree to provide CPT to 6 patients over 2 years
  • Consent to be randomized to one of two study conditions
  • Are willing to record therapy sessions
  • Continue to have computer/internet access.
  • Patients will be clients of clinician participants that
Show all 9Show fewer
  • Are 18 years or older
  • Have a diagnosis of PTSD
  • Are willing to have their sessions audiorecorded

Who cannot join

  • Ineligible patient participants are those having
  • Current uncontrolled psychotic or bipolar disorder
  • Unremitted substance dependence
  • Current imminent suicidality or homicidality that requires imminent attention
  • Significant cognitive impairment

Trial locations and contacts

3 sites in 2 countries.

3 sites in 2 countries

United States2 sites
  • VA Palo Alto Healthcare System

    Menlo Park, California, 94024

  • UTHSCSA

    San Antonio, California, 78229

Other trials in United States

Canada1 site
  • Ryerson University

    Toronto, Ontario, M5B 2K3

Other trials in Canada

About this study

Official title: A Comparison of the Effects of Internet-Based Strategies to Support Mental Health Clinicians' Use of an Effective Psychotherapy for Post Traumatic Stress Disorder (PTSD) in Mental Health Systems

The purpose of the study is to compare the impact of two strategies to sustain and improve the delivery of an evidence-based psychotherapy for PTSD, Cognitive Processing Therapy (CPT) in three different mental health systems. These approaches are based on two different theories of what is necessary to promote successful implementation. We will examine whether these strategies lead to improved patient outcomes, clinician skill, proportion of clients who receive CPT, and other outcomes that are relevant to the implementation of evidence-based psychosocial treatments. By examining these questions in 3 different mental health systems, we will also examine whether the implementation strategies yield different results in different systems.

Read the detailed description

This project will compare two different methods of post-training support to promote sustained and improved CPT delivery: Fidelity-oriented learning community (FID-LC) and Continuous Quality Improvement Learning Community (CQI-LC). Clinics in which clinicians have previously received CPT training will be randomly assigned to one of these conditions. Outcomes will be observed changes in patient symptoms during and following treatment, independent expert assessment of clinician fidelity and adaptations in delivering the psychotherapy (via audio-recordings), proportion of eligible caseloads that receive CPT, and capacity to deliver CPT. Data will also be collected to assess clinician and setting characteristics that may contribute to the success of each strategy. The study results will help inform how best to support the ongoing implementation and benefits of evidence-based psychotherapy (e.g., CPT) in routine clinical settings. This is a knowledge translation project in partnership with 3 systems; VA Canada, U.S. Veterans Health Care System and the National Centre for PTSD.

Being tested
Quality Improvement Learning Community, Fidelity-oriented Learning Community
Keywords
trauma
Medical subject headings
Stress Disorders, Post-Traumatic, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quality Improvement Learning CommunityBehavioural

    Consultation with CPT experts to effectively use evidence-based psychotherapy.

  • Fidelity-oriented Learning CommunityBehavioural

    The Fidelity-oriented Learning Community arm will receive fidelity consultation (adherence and competence) feedback by a CPT expert via online meetings.

Study groups in NCT02449421
Study groupRoleWhat they receive
Fidelity-oriented Learning CommunityExperimentalThe Fidelity-oriented Learning Community arm will receive fidelity consultation (adherence and competence) feedback by a CPT expert via online meetings.
Receives: Behavioral: Fidelity-oriented Learning Community
Quality Improvement Learning CommunityExperimentalThe Quality Improvement Learning Community arm will include clinicians who set goals related to CPT delivery, execute a plan, study results, refine plan, and continue each cycle until goals are met.
Receives: Behavioral: Quality Improvement Learning Community

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PTSD Symptoms over 6 months (PCL-5 measure)

    The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD. Each item is measured on a 5-point Likert scale. The PCL will track change from baseline to the 3 month follow up.

    Measured: Participants will be followed for an expected duration of 12 weeks of therapy. PCL-5 will be measured at baseline, at Weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up.

Secondary outcomes (3)
  1. Fidelity Measure

    The fidelity measure examines clinicians' adherence and competence to specific CPT interventions prescribed in each session. Clinicians are rated on their adherence to the protocol (on a 0-2 Likert-type scale), as well as their competence in delivery of these elements (rated on a 7-point, Likert-type scale).

    Measured: At baseline, at 12 and 24 months

  2. Content-Level and Context-Level Adaptation

    Using a framework and coding system of modifications and adaptations made to EBPs, sessions will be rated to identify 11 potential content-level adaptations, as well as 5 context-level modifications.

    Measured: At baseline, at 12 and 24 months

  3. CPT Activity Reporting

    All clinicians will report monthly on CPT activity: caseload size, frequency, duration and satisfaction with the LC over the past month, number of new CPT patients, clinician confidence rating in their CPT delivery.

    Measured: monthly for up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2015 (estimated)
  2. Study start6 May 2015
  3. Primary completionDec 2022
  4. Study completionJun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02449421
Sponsor's protocol ID
REB: 2014-345
Other IDs
137012, R01MH106506-01
Status last verified
Jan 2024
First submitted
9 Feb 2015
Last updated
17 Jan 2024
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No: No plan to share IPD.

Publications

  • Thomas FC, Loskot T, Mutschler C, Burdo J, Lagdamen J, Sijercic I, Lane JEM, Liebman RE, Finley EP, Monson CM, Wiltsey-Stirman S. Initiating Cognitive Processing Therapy (CPT) in Community Settings: A Qualitative Investigation of Therapist Decision-Making. Adm Policy Ment Health. 2023 Jan;50(1):137-150. doi: 10.1007/s10488-022-01229-8. Epub 2022 Nov 12.

    PubMed 36370226
  • Wiltsey Stirman S, Finley EP, Shields N, Cook J, Haine-Schlagel R, Burgess JF Jr, Dimeff L, Koerner K, Suvak M, Gutner CA, Gagnon D, Masina T, Beristianos M, Mallard K, Ramirez V, Monson C. Improving and sustaining delivery of CPT for PTSD in mental health systems: a cluster randomized trial. Implement Sci. 2017 Mar 6;12(1):32. doi: 10.1186/s13012-017-0544-5.

    PubMed 28264720

Questions about this trial

What is this clinical trial studying?

A study testing Quality Improvement Learning Community and Fidelity-oriented Learning Community in people with Post Traumatic Stress Disorder, run by Toronto Metropolitan University at 3 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States, Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PTSD Symptoms over 6 months (PCL-5 measure) (time frame: Participants will be followed for an expected duration of 12 weeks of therapy. PCL-5 will be measured at baseline, at Weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02449421, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in